Disease, Disability, and Injury Prevention and Control-Special Emphasis Panel: Center To Protect Worker Rights, Program Announcement (PA) 07-318, 36458 [E7-12837]

Download as PDF 36458 Federal Register / Vol. 72, No. 127 / Tuesday, July 3, 2007 / Notices Eastern time by the deadline listed in the DATES section at the beginning of this Notice. V. Responsiveness Criteria Each application submitted will be screened to determine whether it was received by the closing date and time. Applications received by the closing date and time will be screened for completeness and conformity with the requirements outlined in Sections III and IV of this Notice and the Program Announcement. Only complete applications that meet these requirements will be reviewed and evaluated competitively. VI. Application Review Information Eligible applications in response to this announcement will be reviewed according to the following evaluation criteria: • Purpose and Need for Assistance— (20 points) • Approach, Workplan and Activities—(30 points) • Outcomes/Evaluation/ Dissemination—(25 points) • Level of Effort—(25 points). forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of research grant applications in response to PA 07–318, ‘‘Center to Protect Worker Rights.’’ For Further Information Contact: George Bockosh, M.S., Designated Federal Officer, 626 Cochran Mill Road, Pittsburgh, PA 15236, telephone 412.386.6465. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 27, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–12837 Filed 7–2–07; 8:45 am] BILLING CODE 4163–18–P evaluation of individual research grant and cooperative agreement applications submitted in response to one Fiscal Year 2007 Request for Applications related to the following individual research announcement: RFA–CE–07–011, ‘‘Multi-Level Parent Training Effectiveness Trial—Phase II (U49).’’ Agenda items are subject to change as priorities dictate. Contact Person for More Information: Jane Suen, NCIPC/ERPO, CDC, 4770 Buford Highway, NE., M/S K02, Atlanta, Georgia 30341–3724, telephone 770/488–4281, or Tony Johnson, telephone 770/488–1556. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 27, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–12822 Filed 7–2–07; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P VII. Agency Contacts Direct inquiries regarding programmatic issues to U.S. Department of Health and Human Services, Administration on Aging, Office of Evaluation, Washington, DC 20201, telephone: (202) 357–0145. Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES National Center for Injury Prevention and Control Initial Review Group (NCIPC/IRG) Food and Drug Administration Dated: June 28, 2007. Josefina G. Carbonell, Assistant Secretary for Aging. [FR Doc. E7–12858 Filed 7–2–07; 8:45 am] BILLING CODE 4154–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control—Special Emphasis Panel: Center To Protect Worker Rights, Program Announcement (PA) 07–318 jlentini on PROD1PC65 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Time and Date: 1 p.m.–2 p.m., July 18, 2007 (Closed). Place: 626 Cochran Mill Road, Building 20, Room 313, Pittsburgh, PA 15236. Status: The meeting will be closed to the public in accordance with provisions set VerDate Aug<31>2005 17:57 Jul 02, 2007 Jkt 211001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Times and Date: 2 p.m.–2:30 p.m., July 31, 2007 (Open). 2:30 p.m.–5 p.m., July 31, 2007 (Closed). Place: The conference call will originate at the Centers for Disease Control and Prevention, Yale Building, Koger Center, Atlanta, Georgia. Status: Portions of the meetings will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92–463. Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control. Matters To Be Discussed: The meeting will include the review, discussion, and PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 Request for Nominations for Voting Members on Public Advisory Panels or Committees AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is requesting nominations for voting members to serve on the Device Good Manufacturing Practice Advisory Committee, certain device panels of the Medical Devices Advisory Committee, the National Mammography Quality Assurance Advisory Committee, and the Technical Electronic Products Radiation Safety Standards Committee in the Center for Devices and Radiological Health. Nominations will be accepted for current vacancies and those that will or may occur through August 31, 2008. FDA has a special interest in ensuring that women, minority groups, and individuals with disabilities are adequately represented on advisory committees and, therefore, encourages nominations of qualified candidates from these groups. DATES: Because scheduled vacancies occur on various dates throughout each year, no cutoff date is established for the receipt of nominations. However, when E:\FR\FM\03JYN1.SGM 03JYN1

Agencies

[Federal Register Volume 72, Number 127 (Tuesday, July 3, 2007)]
[Notices]
[Page 36458]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-12837]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control--Special 
Emphasis Panel: Center To Protect Worker Rights, Program Announcement 
(PA) 07-318

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:

    Time and Date: 1 p.m.-2 p.m., July 18, 2007 (Closed).
    Place: 626 Cochran Mill Road, Building 20, Room 313, Pittsburgh, 
PA 15236.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of research grant applications in 
response to PA 07-318, ``Center to Protect Worker Rights.''
    For Further Information Contact: George Bockosh, M.S., 
Designated Federal Officer, 626 Cochran Mill Road, Pittsburgh, PA 
15236, telephone 412.386.6465.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: June 27, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E7-12837 Filed 7-2-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.